Not yet "case closed" on EU's human tissue product regulation?
This article was originally published in Clinica
Executive Summary
There is still sufficient strong feeling among those representing medical device manufacturers over the regulation of human tissue engineered products (hTEPS) to suggest that the debate within the European Council on the European Commission's proposed Regulation for Advanced Therapy Products could be both lively and complex.